Ethiopia has taken a new step towards bolstering its healthcare infrastructure with the launch of a US$3.28 million project aimed at developing sustainable vaccine research and manufacturing capabilities. Ethiopian health officials and scientists will visit leading global vaccine manufacturing facilities to adopt best practices and set benchmarks for local vaccine research and production. Moreover, through cutting-edge training initiatives, Ethiopian experts will acquire advanced skills in vaccine production, fostering a skilled workforce to drive the country’s vaccine manufacturing ambitions. These efforts aim to lay the groundwork for a proficient and sustainable vaccine production industry, aligned with Ethiopia’s broader healthcare goals. With over 120 million people, Ethiopia is Africa’s second-most populous nation, making vaccine self-sufficiency critical for long-term public health goals.

Source: Ethiopian News November 19, 2024 03:06 UTC